Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

213 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Facing the challenge of polypharmacy when prescribing for older people with cardiovascular disease. A review by the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy.
Tamargo J, Kjeldsen KP, Delpón E, Semb AG, Cerbai E, Dobrev D, Savarese G, Sulzgruber P, Rosano G, Borghi C, Wassmann S, Torp-Pedersen CT, Agewall S, Drexel H, Baumgartner I, Lewis B, Ceconi C, Kaski JC, Niessner A. Tamargo J, et al. Among authors: niessner a. Eur Heart J Cardiovasc Pharmacother. 2022 Jun 8;8(4):406-419. doi: 10.1093/ehjcvp/pvac005. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 35092425 Review.
High-density lipoprotein cholesterol, coronary artery disease, and cardiovascular mortality.
Silbernagel G, Schöttker B, Appelbaum S, Scharnagl H, Kleber ME, Grammer TB, Ritsch A, Mons U, Holleczek B, Goliasch G, Niessner A, Boehm BO, Schnabel RB, Brenner H, Blankenberg S, Landmesser U, März W. Silbernagel G, et al. Among authors: niessner a. Eur Heart J. 2013 Dec;34(46):3563-71. doi: 10.1093/eurheartj/eht343. Epub 2013 Sep 7. Eur Heart J. 2013. PMID: 24014391 Free article.
C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction.
Koller L, Kleber M, Goliasch G, Sulzgruber P, Scharnagl H, Silbernagel G, Grammer T, Delgado G, Tomaschitz A, Pilz S, März W, Niessner A. Koller L, et al. Among authors: niessner a. Eur J Heart Fail. 2014 Jul;16(7):758-66. doi: 10.1002/ejhf.104. Epub 2014 May 7. Eur J Heart Fail. 2014. PMID: 24806206 Free article.
Von Willebrand factor improves risk prediction in addition to N-terminal pro-B-type natriuretic peptide in patients referred to coronary angiography and signs and symptoms of heart failure and preserved ejection fraction.
Kleber ME, Koller L, Goliasch G, Sulzgruber P, Scharnagl H, Silbernagel G, Grammer TB, Delgado G, Tomaschitz A, Pilz S, März W, Niessner A. Kleber ME, et al. Among authors: niessner a. Circ Heart Fail. 2015 Jan;8(1):25-32. doi: 10.1161/CIRCHEARTFAILURE.114.001478. Epub 2014 Oct 23. Circ Heart Fail. 2015. PMID: 25342739
Reversal strategies for non-vitamin K antagonist oral anticoagulants: a critical appraisal of available evidence and recommendations for clinical management-a joint position paper of the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy and European Society of Cardiology Working Group on Thrombosis.
Niessner A, Tamargo J, Morais J, Koller L, Wassmann S, Husted SE, Torp-Pedersen C, Kjeldsen K, Lewis BS, Drexel H, Kaski JC, Atar D, Storey RF, Lip GYH, Verheugt FWA, Agewall S. Niessner A, et al. Eur Heart J. 2017 Jun 7;38(22):1710-1716. doi: 10.1093/eurheartj/ehv676. Eur Heart J. 2017. PMID: 26705385 No abstract available.
Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology.
Schmidt M, Lamberts M, Olsen AM, Fosbøll E, Niessner A, Tamargo J, Rosano G, Agewall S, Kaski JC, Kjeldsen K, Lewis BS, Torp-Pedersen C. Schmidt M, et al. Among authors: niessner a. Eur Heart J. 2016 Apr 1;37(13):1015-23. doi: 10.1093/eurheartj/ehv505. Epub 2016 Mar 16. Eur Heart J. 2016. PMID: 26984863 Review. No abstract available.
Cardiovascular safety of non-aspirin non-steroidal anti-inflammatory drugs: review and position paper by the working group for Cardiovascular Pharmacotherapy of the European Society of Cardiology.
Schmidt M, Lamberts M, Olsen AM, Fosbøll EL, Niessner A, Tamargo J, Rosano G, Agewall S, Kaski JC, Kjeldsen K, Lewis BS, Torp-Pedersen C. Schmidt M, et al. Among authors: niessner a. Eur Heart J Cardiovasc Pharmacother. 2016 Apr;2(2):108-18. doi: 10.1093/ehjcvp/pvv054. Eur Heart J Cardiovasc Pharmacother. 2016. PMID: 27533522 No abstract available.
213 results